miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma
Open Access
- 11 April 2019
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 20 (1) , 127
Abstract
MicroRNAs have been related to tumor progression in diverse human cancers including clear-cell renal cell carcinoma (ccRCC). Previous study has suggested the important regulation function of miR-10b in ccRCC. However, the direct target of miR-10b in ccRCC and the related molecular mechanisms has not yet been revealed. miR-10b and HOXA3 was detected by qRT-PCR. MTT, colony formation assay, wound-healing and transwell assays were performed to detect cell proliferation, colony formation, migration, and invasion abilities in ccRCC. Western blot analyses were performed to evaluate the protein expression of HOXA3, YAP, FAK and MMP-9. Dual luciferase reporter assay was employed to measure potential molecular mechanism of miR-10b in ccRCC. miR-10b was down-regulated in 786-O and A498 cells as compared to renal tubular HK-2 cells. By contrast, HOXA3 and YAP was up-regulated in ccRCC cells and tissues. Functionally, knockdown of YAP inhibited cell proliferation, migration and invasion. Knockdown of FAK downregulated YAP, in turn, resulted in a decrease of HOXA3 expression. Mechanically, miR-10b targets HOXA3 to exert its tumor-suppressive effect on ccRCC in vitro. These novel data suggest that miR-10b suppresses cell invasion and metastasis through targeting HOXA3, which partially passed through the FAK/YAP signaling pathway.Keywords
Funding Information
- National Science Foundation of China (No. 81770705)
This publication has 30 references indexed in Scilit:
- Genome-Wide MicroRNA Expression Analysis of Clear Cell Renal Cell Carcinoma by Next Generation Deep SequencingPLOS ONE, 2012
- Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patientsGenes, Chromosomes and Cancer, 2012
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogeneOncogene, 2011
- MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutationsHepatology, 2008
- Multi-Institutional Validation of a New Renal Cancer–Specific Survival NomogramJournal of Clinical Oncology, 2007
- Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assayProceedings of the National Academy of Sciences, 2007
- Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 ampliconProceedings of the National Academy of Sciences, 2006
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006
- HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repairJournal of Cell Science, 2005
- Altered expressions of HOX genes in human cutaneous malignant melanomaInternational Journal of Cancer, 2004